IDEAYA Biosciences (IDYA) Deferred Taxes (2018)

IDEAYA Biosciences (IDYA) reported Deferred Taxes of -$37000.0 for Q4 2018, down 94.74% sequentially from -$19000.0 in Q3 2018.

IDEAYA Biosciences (IDYA) Deferred Taxes (2018) Analysis & Trends

IDEAYA Biosciences (IDYA) has 1 years of Deferred Taxes data on file, last reported at -$37000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 IDEAYA Biosciences 3.21 Bn 2.54 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 -37,000.00
Sep 30, 2018 -19,000.00